Sensome

From Bio-Impedance to Clinical Insights

Massy · Founded 2014 · $27.6M raised

Headquarters
Massy
Founded
2014
Business Model
B2B
Total Funding
$27.6M
Last Round
$7.9M Series CJul 2024
Rounds
4

About

Sensome develops tissue-sensing microchip technology that gives physicians real-time, patient-specific tissue information during minimally invasive medical procedures. Its lead product, the Clotild Smart Guidewire System, manufactured with Asahi Intecc, is a tissue-sensing neurovascular guidewire pursuing regulatory clearance in the EU, US, and Japan for treating acute ischemic stroke. The bio-impedance sensing platform has also shown clinical feasibility in lung cancer biopsy guidance and peripheral vascular intervention; the company was formerly known as Insent.

Summary

Sensome is a Biotech company based in Massy, founded in 2014. It has raised $27.6M in total across 4 rounds, most recently a $7.9M Series C round in Jul 2024.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CJul 2024
$7.9M

Sign up to see all 4 rounds

Seed through Series C — per-round amounts, valuations, and who invested in each round.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Sensome on Indexed.vc
<a href="https://indexed.vc/companies/sensome"><img src="https://indexed.vc/api/badge/company/sensome" alt="Sensome on Indexed.vc" width="260" height="76" /></a>